Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy

PHASE3TerminatedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

December 7, 2021

Primary Completion Date

November 27, 2023

Study Completion Date

November 27, 2023

Conditions
Allergy, Peanut
Interventions
DRUG

ligelizumab

Subcutaneous injection once every 4 weeks

DRUG

Placebo

Subcutaneous injection once every 4 weeks

Trial Locations (55)

3052

Novartis Investigative Site, Parkville

4101

Novartis Investigative Site, Brisbane

5000

Novartis Investigative Site, Odense

6009

Novartis Investigative Site, Nedlands

10028

Northwell Health, New York

13353

Novartis Investigative Site, Berlin

14203

UBMD Pediatrics, Buffalo

19104

Childrens Hospital Of Philadelphia, Philadelphia

21287

Johns Hopkins Childrens Center, Baltimore

28009

Novartis Investigative Site, Madrid

28040

Novartis Investigative Site, Madrid

30062

Atlanta Allergy and Asthma Clinic, Marietta

30342

Childrens Healthcare of Atlanta, Atlanta

31400

Novartis Investigative Site, Toulouse

33613

Univ of South Florida Asthma Allergy and Immunology CRU, Tampa

35128

Novartis Investigative Site, Padua

35209

Allervie Clinical Research, Birmingham

40217

Family Allergy and Asthma, Louisville

45231

Bernstein Clinical Research Center, Cincinnati

46202

Indiana University, Indianapolis

48109

University of Michigan Clinical Trials Office, Ann Arbor

48197

Respiratory Medicine Research Institute of Michigan, Ypsilanti

49933

Novartis Investigative Site, Angers

54511

Novartis Investigative Site, Vandœuvre-lès-Nancy

59000

Novartis Investigative Site, Lille

60590

Novartis Investigative Site, Frankfurt

60596

Novartis Investigative Site, Frankfurt

60611

Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago

72202

Arkansas Children's Hospital, Little Rock

75235

University of Texas Southwestern Medical Center, Dallas

77030

Texas Childrens Hospital, Houston

80045

UCHealth Outpatient Pavilion, Aurora

80230

Colorado Allergy and Asthma Ctr PC, Denver

80907

Asthma and Allergy Associates P C, Colorado Springs

85251

Allergy and Immunology Associates, Scottsdale

94598

Allergy and Asthma Clinical Research Inc, Walnut Creek

95117

Allergy and Asthma Associates of Santa Clara Vally Center, San Jose

98115

Seattle Allergy and Asthma Rsch, Seattle

02114

Massachusetts General Hospital, Boston

02215

Boston Childrens Hospital, Boston

10029-6574

Mt Sinai Medical Center, New York

27599 9500

University Of NC At Chapel Hill, Chapel Hill

45229-3039

Cincinnati Childrens Hospital MC, Cincinnati

L8N 3Z5

Novartis Investigative Site, Hamilton

K1Y 4G2

Novartis Investigative Site, Ottawa

M3B 3S6

Novartis Investigative Site, Toronto

H3T 1C5

Novartis Investigative Site, Montreal

G1V 4W2

Novartis Investigative Site, Québec

01307

Novartis Investigative Site, Dresden

252-0392

Novartis Investigative Site, Sagamihara

157-8535

Novartis Investigative Site, Setagaya-ku

142-8666

Novartis Investigative Site, Shinagawa-ku

3584CX

Novartis Investigative Site, Utrecht

08950

Novartis Investigative Site, Esplugues de Llobregat

08036

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY